Celsis Accel System for Rapid Microbial Screening


Celsis is proud to announce the new Celsis Accel, a rapid microbial screening system designed for small to medium-size Home and Beauty manufacturers.

Celsis Accel System for Rapid Microbial Screening

As the world’s leading innovator in rapid methods, Celsis systems are used globally by leading manufacturers in the Home and Beauty industries. Celsis systems deliver quality control results in just 18–24 hours, enabling you to reduce micro hold times and quickly release to market. This eliminates days from your production cycle time, decreases inventory and working-capital requirements, reduces warehousing costs and improves your company’s overall profitability.

Quantifiable Savings

With its Financial Impact Assessment (FIA), Celsis can evaluate the cost savings of implementing a Celsis Accel system in your manufacturing facility. Using readily available company-specific information including the daily value of finished goods, testing volume and the number of days products are held in quarantine, the FIA projects the 5-year Net Present Value (NPV) of your company’s investment in the Celsis system. The 5-year NPV for an average small to medium-size manufacturing facility is in excess of $300,000, and most plants realise a return on investment in just 6–9 months.

Utilizing Celsis’ proprietary reagent technology, the Celsis Accel system delivers quality control results in just 18–24 hours, enabling you to rapidly confirm the quality of your product and quickly release to market.

The Celsis Accel takes the robustness and ease-of-use of the widely adopted Celsis Advance platform packaged into a small footprint specifically designed for small and medium-size manufacturing facilities.

Easy-to-use and easy-to-learn, Accel system features include:

  • Runs up to 30 tests per hour
  • Designed for ease-of-use
  • Ability to export sample results
  • On-screen instructions for routine tasks
  • Allows full compliance with the FDA’s 21 CFR Part 11 and the European Union’s Annex 11

Additional Celsis Accel Specifications Include:

User Interface:

Accel.im software utilises a familiar top-ribbon/drop-down menu design for intuitive, ease-of-use. Reagent levels are easily monitored with a colour-coded graphic display that’s on-screen all the time along with a workload timer.

Carousel Architecture:

The 30 position carousel is integrated into a light sealed chamber accessible through a motor actuated door allowing easy access.

Ergonomic Design:

All user accessible features are ergonomically positioned in front of the instrument for easy access.

Added Security with One Click Lock Out:

In addition to the option of locking data once the run begins, users have the ability to lock the application with a single mouse click in order to ensure that the run is uninterrupted.

Fourth Injector Capability:

The Accel system ships standard with three injectors but with the option of a fourth injector, giving the system additional flexibility to incorporate new reagent technology.

On Screen Help:

A comprehensive topic-based and searchable help file provides on-screen instructions for performing routine tasks as well as detailed information about a range of topics from software customisation to user administration.

Modular Electronics:

The use of modular electronics simplifies service, customisation and upgrading.

Data Export:

Accel.im can export an individual batch or the entire workload to an array of file formats used by LIM systems.

User Administration and Security:

Administration utility allows efficient management of user access and function permissions.

System Log:

Sign up for your free email newsletter

An unlimited system log records events by each user and maintains records for the lifetime of the installation. Allows compliance with 21 CFR Part 11 and Annex 11 regulatory requirements.

Featured Companies